Baird Capital closes $185 mln for fourth venture fund
Baird Capital, the private investment arm of Robert W. Baird & Co., has raised $185 million for its oversubscribed fourth venture capital fund, sweeping past its $150 million target. Fund IV's LP base includes numerous institutions, foundations and family offices. So far, the fund has made investments in Catalyze, emids, Integrated Diagnostics, NeuMoDx Molecular and WordStream.
18 November 2014•2 mins read
